Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

English (EN)·Polski (PL)·Ukraiński (UK)
Przejdź do strony domowej biblioteki Uniwersytet Ekonomiczny we Wrocławiu Link otwiera się w nowym oknie Logo biblioteki Prolib Integro - strona głównaUniwersytet Ekonomiczny we Wrocławiu

Wyszukujesz frazę ""Lobbes MBI"" wg kryterium: Autor

  Lista filtrów
Wyrównaj
    Wyświetlanie 1-12 z 12
    Tytuł:
    Prediction of Primary Tumour and Axillary Lymph Node Response to Neoadjuvant Chemo(Targeted) Therapy with Dedicated Breast [18F]FDG PET/MRI in Breast Cancer.
    Autorzy:
    de Mooij CM; Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands.; Department of Surgery, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands.; GROW-School for Oncology and Reproduction, Maastricht University, Universiteitssingel 40, 6229 ER Maastricht, The Netherlands.
    van Nijnatten TJA; Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands.; GROW-School for Oncology and Reproduction, Maastricht University, Universiteitssingel 40, 6229 ER Maastricht, The Netherlands.
    Goorts B; Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands.; Department of Surgery, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands.; GROW-School for Oncology and Reproduction, Maastricht University, Universiteitssingel 40, 6229 ER Maastricht, The Netherlands.
    Kooreman LFS; GROW-School for Oncology and Reproduction, Maastricht University, Universiteitssingel 40, 6229 ER Maastricht, The Netherlands.; Department of Pathology, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands.
    Raymakers IWM; Department of Surgery, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands.
    van Meijl SPL; Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands.
    de Boer M; Department of Medical Oncology, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands.
    Keymeulen KBMI; Department of Surgery, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands.
    Wildberger JE; Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands.
    Mottaghy FM; Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands.; Department of Nuclear Medicine, RWTH Aachen University Hospital, Pauwelstraße 30, 52074 Aachen, Germany.
    Lobbes MBI; Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands.; GROW-School for Oncology and Reproduction, Maastricht University, Universiteitssingel 40, 6229 ER Maastricht, The Netherlands.; Department of Medical Imaging, Zuyderland Medical Centre, Dr. H. van der Hoffplein 1, 6162 BG Sittard-Geleen, The Netherlands.
    Smidt ML; Department of Surgery, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX Maastricht, The Netherlands.; GROW-School for Oncology and Reproduction, Maastricht University, Universiteitssingel 40, 6229 ER Maastricht, The Netherlands.
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2023 Jan 07; Vol. 15 (2). Date of Electronic Publication: 2023 Jan 07.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    The diagnostic value of contrast-enhanced 2D mammography in everyday clinical use.
    Autorzy:
    Neeter LMFH; GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands. .; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands. .
    Raat HPJ; Department of Medical Imaging, Laurentius Hospital, Roermond, The Netherlands.
    Meens-Koreman SD; Department of Medical Imaging, Laurentius Hospital, Roermond, The Netherlands.
    van Stiphout RSA; Department of Medical Imaging, Laurentius Hospital, Roermond, The Netherlands.
    Timmermans SMEC; Department of Medical Imaging, Laurentius Hospital, Roermond, The Netherlands.
    Duvivier KM; Department of Radiology and Nuclear Medicine, Amsterdam UMC, Cancer Center Amsterdam, Vrije Universiteit Amsterdam, Amsterdam, The Netherlands.
    Smidt ML; GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.; Department of Surgery, Maastricht University Medical Center+, Maastricht, The Netherlands.
    Wildberger JE; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands.
    Nelemans PJ; Department of Epidemiology, Maastricht University, Maastricht, The Netherlands.
    Lobbes MBI; GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands.; Department of Medical Imaging, Zuyderland Medical Center, Sittard-Geleen, The Netherlands.
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2021 Nov 15; Vol. 11 (1), pp. 22224. Date of Electronic Publication: 2021 Nov 15.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Breast/*diagnostic imaging
    Breast/*pathology
    Breast Neoplasms/*diagnosis
    Mammography/*methods
    Adult ; Aged ; Aged, 80 and over ; Biomarkers, Tumor ; Breast Neoplasms/epidemiology ; Breast Neoplasms/etiology ; Clinical Decision-Making ; Contrast Media ; Disease Management ; Female ; Humans ; Magnetic Resonance Imaging ; Mammography/standards ; Mass Screening ; Middle Aged ; ROC Curve ; Radiographic Image Enhancement ; Reproducibility of Results ; Sensitivity and Specificity ; Tomography, X-Ray Computed
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    MRI-Based Radiomics Analysis for the Pretreatment Prediction of Pathologic Complete Tumor Response to Neoadjuvant Systemic Therapy in Breast Cancer Patients: A Multicenter Study.
    Autorzy:
    Granzier RWY; Department of Surgery, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands.; GROW-School for Oncology and Developmental Biology, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands.
    Ibrahim A; GROW-School for Oncology and Developmental Biology, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands.; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands.; The D-Lab, Department of Precision Medicine, Maastricht University, Universiteitssingel 40, 6229 ER Maastricht, The Netherlands.; Division of Nuclear Medicine and Oncological Imaging, Department of Medical Physics, University Hospital of Liège and GIGA CRC-In Vivo Imaging, University of Liège, 4000 Liege, Belgium.; Department of Nuclear Medicine and Comprehensive Diagnostic Center Aachen (CDCA), University Hospital RWTH Aachen University, 52074 Aachen, Germany.
    Primakov SP; GROW-School for Oncology and Developmental Biology, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands.; The D-Lab, Department of Precision Medicine, Maastricht University, Universiteitssingel 40, 6229 ER Maastricht, The Netherlands.
    Samiei S; Department of Surgery, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands.; GROW-School for Oncology and Developmental Biology, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands.; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands.
    van Nijnatten TJA; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands.
    de Boer M; GROW-School for Oncology and Developmental Biology, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands.; Department of Internal Medicine, Division of Medical Oncology, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands.
    Heuts EM; Department of Surgery, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands.
    Hulsmans FJ; Department of Medical Imaging, Zuyderland Medical Center, P.O. Box 5500, 6130 MB Sittard-Geleen, The Netherlands.
    Chatterjee A; GROW-School for Oncology and Developmental Biology, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands.; The D-Lab, Department of Precision Medicine, Maastricht University, Universiteitssingel 40, 6229 ER Maastricht, The Netherlands.
    Lambin P; GROW-School for Oncology and Developmental Biology, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands.; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands.; The D-Lab, Department of Precision Medicine, Maastricht University, Universiteitssingel 40, 6229 ER Maastricht, The Netherlands.
    Lobbes MBI; GROW-School for Oncology and Developmental Biology, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands.; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands.; Department of Medical Imaging, Zuyderland Medical Center, P.O. Box 5500, 6130 MB Sittard-Geleen, The Netherlands.
    Woodruff HC; GROW-School for Oncology and Developmental Biology, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands.; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands.; The D-Lab, Department of Precision Medicine, Maastricht University, Universiteitssingel 40, 6229 ER Maastricht, The Netherlands.
    Smidt ML; Department of Surgery, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands.; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands.
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2021 May 18; Vol. 13 (10). Date of Electronic Publication: 2021 May 18.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Impact of the COVID-19 pandemic on diagnosis, stage, and initial treatment of breast cancer in the Netherlands: a population-based study.
    Autorzy:
    Eijkelboom AH; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511 DT, Utrecht, The Netherlands.
    de Munck L; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511 DT, Utrecht, The Netherlands.
    Vrancken Peeters MTFD; Department of Surgery, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Department of Surgery, Amsterdam UMC, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
    Broeders MJM; Department for Health Evidence, Radboud University Medical Center, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands.; Dutch Expert Centre for Screening, Wijchenseweg 101, 6538 SW, Nijmegen, The Netherlands.
    Strobbe LJA; Department of Surgical Oncology, Canisius Wilhelmina Hospital, Weg door Jonkerbos 100, 6532 SZ, Nijmegen, The Netherlands.
    Bos MEMM; Department of Medical Oncology, Erasmus Medical Centre Cancer Institute, Doctor Molewaterplein 40, 3015 GD, Rotterdam, The Netherlands.
    Schmidt MK; Division of Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.
    Guerrero Paez C; Dutch Breast Cancer Society (BVN), Godebaldkwartier 363, 3511 DT, Utrecht, The Netherlands.
    Smidt ML; Department of Surgery, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX, Maastricht, the Netherlands.; GROW School for Oncology and Development Biology, Maastricht University, Univeristeitssingel 40, 6220 ER, Maastricht, the Netherlands.
    Bessems M; Department of Surgery, Jeroen Bosch Hospital, Henri Dunantstraat 1, 5223 GZ, 's-Hertogenbosch, The Netherlands.
    Verloop J; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511 DT, Utrecht, The Netherlands.
    Linn S; Division of Diagnostic Oncology and Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Department of Pathology, University Medical Center Utrecht, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
    Lobbes MBI; GROW School for Oncology and Development Biology, Maastricht University, Univeristeitssingel 40, 6220 ER, Maastricht, the Netherlands.; Department of Medical Imaging, Zuyderland Medical Center, Sittard-Geleen, Dr. H. van der Hoffplein 1, 6162 BG, Geleen, The Netherlands.; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, P. Debyelaan 25, 6229 HX, Maastricht, The Netherlands.
    Honkoop AH; Department of Medical Oncology, Isala Clinics, Dokter van Heesweg 2, 8025 AB, Zwolle, The Netherlands.
    van den Bongard DHJG; Department of Radiation Oncology, Amsterdam UMC, Meibergdreef 9, 1105 AZ, Amsterdam, The Netherlands.
    Westenend PJ; Laboratory of Pathology, Karel Lotsyweg 145, 3318 AL, Dordrecht, The Netherlands.
    Wesseling J; Division of Diagnostic Oncology and Molecular Pathology, Netherlands Cancer Institute-Antoni van Leeuwenhoek Hospital, Plesmanlaan 121, 1066 CX, Amsterdam, The Netherlands.; Department of Pathology, Leiden University Medical Center, Albinusdreef 2, 2333 ZA, Leiden, The Netherlands.
    Menke-van der Houven van Oordt CW; Department of Medical Oncology, Cancer Center Amsterdam, Amsterdam UMC, Location Vrije Universiteit Medical Centre, De Boelelaan 1117, 1081 HV, Amsterdam, The Netherlands.
    Tjan-Heijnen VCG; Department of Medical Oncology, Maastricht University Medical Centre, P. Debyelaan 25, 6229 HX, Maastricht, The Netherlands.
    Siesling S; Department of Research and Development, Netherlands Comprehensive Cancer Organisation (IKNL), Godebaldkwartier 419, 3511 DT, Utrecht, The Netherlands. .; Department of Health Technology and Services Research, Technical Medical Centre, University of Twente, Drienerlolaan 5, 7522 NB, Enschede, The Netherlands. .
    Pokaż więcej
    Corporate Authors:
    NABON COVID-19 Consortium and the COVID and Cancer-NL Consortium
    Źródło:
    Journal of hematology & oncology [J Hematol Oncol] 2021 Apr 17; Vol. 14 (1), pp. 64. Date of Electronic Publication: 2021 Apr 17.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Breast Neoplasms/*diagnosis
    Breast Neoplasms/*therapy
    Adult ; Aged ; Breast Neoplasms/epidemiology ; Breast Neoplasms/pathology ; COVID-19/epidemiology ; Disease Management ; Female ; Humans ; Incidence ; Mass Screening ; Middle Aged ; Neoplasm Staging ; Netherlands/epidemiology
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Dedicated Axillary MRI-Based Radiomics Analysis for the Prediction of Axillary Lymph Node Metastasis in Breast Cancer.
    Autorzy:
    Samiei S; Department of Surgery, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands.; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands.; GROW-School for Oncology and Developmental Biology, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands.
    Granzier RWY; Department of Surgery, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands.; GROW-School for Oncology and Developmental Biology, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands.
    Ibrahim A; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands.; GROW-School for Oncology and Developmental Biology, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands.; The D-Lab, Department of Precision Medicine, Maastricht University, Universiteitssingel 40, 6229 ER Maastricht, The Netherlands.; Division of Nuclear Medicine and Oncological Imaging, Department of Medical Physics, Hospital Center Universitaire de Liege, Rue de Gaillarmont 600, 4030 Liege, Belgium.; Department of Nuclear Medicine and Comprehensive Diagnostic Center Aachen (CDCA), University Hospital RWTH Aachen University, Pauwelsstrasse 30, 52074 Aachen, Germany.
    Primakov S; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands.; GROW-School for Oncology and Developmental Biology, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands.; The D-Lab, Department of Precision Medicine, Maastricht University, Universiteitssingel 40, 6229 ER Maastricht, The Netherlands.
    Lobbes MBI; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands.; GROW-School for Oncology and Developmental Biology, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands.; Department of Medical Imaging, Zuyderland Medical Center, P.O. Box 5500, 6130 MB Sittard-Geleen, The Netherlands.
    Beets-Tan RGH; GROW-School for Oncology and Developmental Biology, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands.; Department of Radiology, The Netherlands Cancer Institute, P.O. Box 90203, 1006 BE Amsterdam, The Netherlands.
    van Nijnatten TJA; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands.
    Engelen SME; Department of Surgery, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands.
    Woodruff HC; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands.; GROW-School for Oncology and Developmental Biology, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands.; The D-Lab, Department of Precision Medicine, Maastricht University, Universiteitssingel 40, 6229 ER Maastricht, The Netherlands.
    Smidt ML; Department of Surgery, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ Maastricht, The Netherlands.; GROW-School for Oncology and Developmental Biology, Maastricht University, P.O. Box 616, 6200 MD Maastricht, The Netherlands.
    Pokaż więcej
    Źródło:
    Cancers [Cancers (Basel)] 2021 Feb 12; Vol. 13 (4). Date of Electronic Publication: 2021 Feb 12.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    MRI-based radiomics in breast cancer: feature robustness with respect to inter-observer segmentation variability.
    Autorzy:
    Granzier RWY; Department of Surgery, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands. .; GROW - School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands. .
    Verbakel NMH; Department of Surgery, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands.
    Ibrahim A; GROW - School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands.; The D-Lab, Department of Precision Medicine, Maastricht University, Maastricht, The Netherlands.; Division of Nuclear Medicine and Oncological Imaging, Department of Medical Physics, Hospital Center Universitaire De Liege, Liège, Belgium.; Department of Nuclear Medicine and Comprehensive Diagnostic Center Aachen (CDCA), University Hospital RWTH Aachen University, Aachen, Germany.
    van Timmeren JE; GROW - School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.; The D-Lab, Department of Precision Medicine, Maastricht University, Maastricht, The Netherlands.
    van Nijnatten TJA; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands.
    Leijenaar RTH; GROW - School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.; The D-Lab, Department of Precision Medicine, Maastricht University, Maastricht, The Netherlands.
    Lobbes MBI; GROW - School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands.; Department of Medical Imaging, Zuyderland Medical Center, Sittard-Geleen, The Netherlands.
    Smidt ML; Department of Surgery, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands.; GROW - School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.
    Woodruff HC; GROW - School for Oncology and Developmental Biology, Maastricht University, Maastricht, The Netherlands.; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, Maastricht, The Netherlands.; The D-Lab, Department of Precision Medicine, Maastricht University, Maastricht, The Netherlands.
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2020 Aug 25; Vol. 10 (1), pp. 14163. Date of Electronic Publication: 2020 Aug 25.
    Typ publikacji:
    Journal Article; Research Support, Non-U.S. Gov't
    MeSH Terms:
    Image Interpretation, Computer-Assisted*
    Observer Variation*
    Breast Neoplasms/*diagnostic imaging
    Computational Biology/*methods
    High-Throughput Screening Assays/*methods
    Imaging, Three-Dimensional/*methods
    Magnetic Resonance Imaging/*methods
    Female ; Humans ; Magnetic Resonance Imaging/statistics & numerical data ; Neoplasm Invasiveness/diagnostic imaging ; Retrospective Studies ; Software
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Image-guided breast biopsy and localisation: recommendations for information to women and referring physicians by the European Society of Breast Imaging.
    Autorzy:
    Bick U; Clinic of Radiology, Charité Universitätsmedizin Berlin, 10117, Berlin, Germany.
    Trimboli RM; PhD Course in Integrative Biomedical Research, Department of Biomedical Science for Health, Università degli Studi di Milano, Via Mangiagalli, 31, 20133, Milan, Italy.
    Athanasiou A; Breast Imaging Department, MITERA Hospital, 6, Erithrou Stavrou Str. 151 23 Marousi, Athens, Greece.
    Balleyguier C; Department of Radiology, Gustave-Roussy Cancer Campus, 114 Rue Edouard Vaillant, 94800, Villejuif, France.
    Baltzer PAT; Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Wien, Austria.
    Bernathova M; Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Wien, Austria.
    Borbély K; MH EK Honvédkórház, Róbert károly krt. 44, Budapest, 1134, Hungary.
    Brkljacic B; Department of Diagnostic and Interventional Radiology, University Hospital Dubrava, University of Zagreb School of Medicine, Zagreb, Croatia.
    Carbonaro LA; Unit of Radiology, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.
    Clauser P; Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Wien, Austria.
    Cassano E; Breast Imaging Division, European Institute of Oncology, Milan, Italy.
    Colin C; Radiology Unit, Hospices Civils de Lyon, Centre Hospitalo-Universitaire Femme Mère Enfant, 59 Boulevard Pinel, 69 677, Bron Cedex, France.
    Esen G; School of Medicine, Department of Radiology, Acıbadem Mehmet Ali Aydınlar University, Istanbul, Turkey.
    Evans A; Dundee Cancer Centre, Clinical Research Centre, Ninewells Hospital and Medical School, Tom McDonald Avenue, Dundee, UK.
    Fallenberg EM; Diagnostic and Interventional Breast Imaging, Department of Radiology, University Hospital, LMU Munich, Marchioninistr. 15, 81377, Munich, Germany.
    Fuchsjaeger MH; Division of General Radiology, Department of Radiology, Medical University Graz, Auenbruggerplatz 9, 8036, Graz, Austria.
    Gilbert FJ; Department of Radiology, University of Cambridge, Cambridge Biomedical Campus, Hills road, Cambridge, CB2 0QQ, UK.
    Helbich TH; Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Wien, Austria.
    Heywang-Köbrunner SH; Referenzzentrum Mammographie München and FFB gGmbH München, Sonnenstraße 29, 80331, Munich, Germany.
    Herranz M; CyclotronUnit, GALARIA-SERGAS, Nuclear Medicine Department and Molecular ImagingGroup, Instituto de Investigación Sanitaria (IDIS), Santiago de Compostela, Spain.
    Kinkel K; Institut de Radiologie, Clinique des Grangettes, Chemin des Grangettes 7, 1224 Chêne-Bougeries, Genève, Switzerland.
    Kilburn-Toppin F; Department of Radiology, University of Cambridge, Cambridge Biomedical Campus, Hills road, Cambridge, CB2 0QQ, UK.
    Kuhl CK; University Hospital of Aachen, Rheinisch-Westfälische Technische Hochschule, Pauwelsstraße 30, 52074, Aachen, Germany.
    Lesaru M; Radiology and Imaging Laboratory, Fundeni Institute, Bucharest, Romania.
    Lobbes MBI; Department of Radiology, Zuyderland Medical Center, Dr. H. van der Hoffplein 1, PO Box 5500, 6130 MB, Sittard-Geleen, The Netherlands.
    Mann RM; Department of Radiology, Radboud University Nijmegen Medical Centre, Geert Grooteplein Zuid 10, 6525 GA, Nijmegen, The Netherlands.
    Martincich L; Unit of Radiodiagnostics ASL AT, Via Conte Verde 125, 14100, Asti, Italy.
    Panizza P; Breast Imaging Unit, Scientific Institute (IRCCS) Ospedale San Raffaele, Via Olgettina, 60, 20132, Milan, Italy.
    Pediconi F; Department of Radiological, Oncological and Pathological Sciences, Sapienza University of Rome, Viale Regina Elena, 324, 00161, Rome, Italy.
    Pijnappel RM; Department of Imaging, University Medical Centre Utrecht, Utrecht University, Heidelberglaan 100, 3584 CX, Utrecht, The Netherlands.
    Pinker K; Department of Biomedical Imaging and Image-guided Therapy, Division of Molecular and Gender Imaging, Medical University of Vienna, Waehringer Guertel 18-20, 1090, Wien, Austria.; Department of Radiology, Breast Imaging Service, Memorial Sloan Kettering Cancer Center, 300 E 66th Street, New York, NY, 10065, USA.
    Schiaffino S; Unit of Radiology, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy.
    Sella T; Department of Diagnostic Imaging, Hadassah Hebrew University Medical Center, Jerusalem, Israel.
    Thomassin-Naggara I; Department of Radiology, Sorbonne Université, APHP, Hôpital Tenon, 4, rue de la Chine, 75020, Paris, France.
    Tardivon A; Department of Radiology, Institut Curie, Paris, France.
    Ongeval CV; Department of Radiology, University Hospitals Leuven, Herestraat 49, 3000, Leuven, Belgium.
    Wallis MG; Cambridge Breast Unit and NIHR Biomedical Research Unit, Box 97, Cambridge University Hospitals NHS Foundation Trust, Cambridge Biomedical Campus, Hills Road, Cambridge, CB2 0QQ, UK.
    Zackrisson S; Diagnostic Radiology, Department of Translational Medicine, Faculty of Medicine, Lund University, Skåne University Hospital Malmö, SE-205 02, Malmö, Sweden.
    Forrai G; Department of Radiology, Duna Medical Center, Budapest, Hungary.
    Herrero JC; Jefa Corporativa del Área de la Mama, Ribera Salud Grupo, Valencia, Spain.
    Sardanelli F; Unit of Radiology, IRCCS Policlinico San Donato, San Donato Milanese, Milan, Italy. .; Department of Biomedical Sciences for Health, Università degli Studi di Milano, Via Morandi 30, 20097 San Donato Milanese, Milan, Italy. .
    Pokaż więcej
    Corporate Authors:
    European Society of Breast Imaging (EUSOBI), with language review by Europa Donna–The European Breast Cancer Coalition
    Źródło:
    Insights into imaging [Insights Imaging] 2020 Feb 05; Vol. 11 (1), pp. 12. Date of Electronic Publication: 2020 Feb 05.
    Typ publikacji:
    Journal Article
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Rapid Access to Contrast-Enhanced spectral mammogRaphy in women recalled from breast cancer screening: the RACER trial study design.
    Autorzy:
    Neeter LMFH; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ, Maastricht, the Netherlands.; GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands.
    Houben IPL; Department of Medical Imaging, Zuyderland Medical Center, Sittard-Geleen, the Netherlands.
    Nelemans PJ; Department of Epidemiology, Maastricht University, Maastricht, the Netherlands.
    Van Nijnatten TJA; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ, Maastricht, the Netherlands.; GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands.
    Pijnappel RM; Department of Radiology, University Medical Center Utrecht, Utrecht, the Netherlands.
    Frotscher C; Department of Medical Imaging, Zuyderland Medical Center, Sittard-Geleen, the Netherlands.
    Osinga-de Jong M; Department of Medical Imaging, Zuyderland Medical Center, Sittard-Geleen, the Netherlands.
    Sanders F; Department of Radiology, Diakonessenhuis, Utrecht, the Netherlands.
    Van Dalen T; Department of Surgery, Diakonessenhuis, Utrecht, the Netherlands.
    Raat HPJ; Department of Radiology, Laurentius Hospital, Roermond, the Netherlands.
    Essers BAB; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Center+, Maastricht, the Netherlands.
    Wildberger JE; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ, Maastricht, the Netherlands.
    Smidt ML; GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands.; Department of Surgery, Maastricht University Medical Center+, Maastricht, the Netherlands.
    Lobbes MBI; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ, Maastricht, the Netherlands. mbi.lobbes@gmail.com.; GROW School for Oncology and Developmental Biology, Maastricht University, Maastricht, the Netherlands. mbi.lobbes@gmail.com.; Department of Medical Imaging, Zuyderland Medical Center, Sittard-Geleen, the Netherlands. mbi.lobbes@gmail.com.
    Pokaż więcej
    Źródło:
    Trials [Trials] 2019 Dec 23; Vol. 20 (1), pp. 759. Date of Electronic Publication: 2019 Dec 23.
    Typ publikacji:
    Clinical Trial Protocol; Journal Article
    MeSH Terms:
    Breast Neoplasms/*diagnostic imaging
    Early Detection of Cancer/*methods
    Mammography/*methods
    Anxiety/psychology ; Biopsy, Fine-Needle ; Biopsy, Large-Core Needle ; Breast Neoplasms/blood supply ; Contrast Media ; Cost-Benefit Analysis ; Early Detection of Cancer/economics ; Early Detection of Cancer/psychology ; Female ; Health Care Costs ; Health Services Accessibility ; Humans ; Magnetic Resonance Imaging ; Mammography/economics ; Mammography/psychology ; Netherlands ; Ultrasonography, Mammary ; Randomized Controlled Trials as Topic
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Diagnostic performance of axillary ultrasound and standard breast MRI for differentiation between limited and advanced axillary nodal disease in clinically node-positive breast cancer patients.
    Autorzy:
    Samiei S; Department of Surgery, Maastricht University Medical Centre+, Maastricht, The Netherlands. .; Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands. .; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, The Netherlands. .
    van Nijnatten TJA; Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.
    van Beek HC; Department of Radiology, Maxima Medical Centre, Eindhoven, The Netherlands.
    Polak MPJ; Department of Radiology, Maxima Medical Centre, Eindhoven, The Netherlands.
    Maaskant-Braat AJG; Department of Surgery, Maxima Medical Centre, Eindhoven, The Netherlands.
    Heuts EM; Department of Surgery, Maastricht University Medical Centre+, Maastricht, The Netherlands.
    van Kuijk SMJ; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre+, Maastricht, The Netherlands.
    Schipper RJ; Department of Surgery, Maastricht University Medical Centre+, Maastricht, The Netherlands.
    Lobbes MBI; Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre+, Maastricht, The Netherlands.; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
    Smidt ML; Department of Surgery, Maastricht University Medical Centre+, Maastricht, The Netherlands.; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre+, Maastricht, The Netherlands.
    Pokaż więcej
    Źródło:
    Scientific reports [Sci Rep] 2019 Nov 25; Vol. 9 (1), pp. 17476. Date of Electronic Publication: 2019 Nov 25.
    Typ publikacji:
    Comparative Study; Journal Article
    MeSH Terms:
    Axilla/*pathology
    Breast Neoplasms/*diagnostic imaging
    Lymphatic Metastasis/*diagnostic imaging
    Adult ; Aged ; Axilla/diagnostic imaging ; Axilla/surgery ; Breast Neoplasms/pathology ; Diagnosis, Differential ; Female ; Humans ; Lymph Node Excision ; Lymphatic Metastasis/pathology ; Magnetic Resonance Imaging ; Middle Aged ; Observer Variation ; Radiographic Image Interpretation, Computer-Assisted ; Sensitivity and Specificity ; Ultrasonography
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Added value of dedicated axillary hybrid 18F-FDG PET/MRI for improved axillary nodal staging in clinically node-positive breast cancer patients: a feasibility study.
    Autorzy:
    van Nijnatten TJA; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands. .; Department of Surgery, Maastricht University Medical Center+, Maastricht, The Netherlands. .; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands. .
    Goorts B; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands.; Department of Surgery, Maastricht University Medical Center+, Maastricht, The Netherlands.; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands.
    Vöö S; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands.
    de Boer M; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands.; Division of Internal Medicine, Department of Medical Oncology, Maastricht University Medical Center+, Maastricht, The Netherlands.
    Kooreman LFS; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands.; Department of Pathology, Maastricht University Medical Center+, Maastricht, The Netherlands.
    Heuts EM; Department of Surgery, Maastricht University Medical Center+, Maastricht, The Netherlands.
    Wildberger JE; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands.
    Mottaghy FM; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands.; Department of Nuclear Medicine, University Hospital, RWTH Aachen University, Aachen, Germany.
    Lobbes MBI; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center+, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands.; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands.
    Smidt ML; Department of Surgery, Maastricht University Medical Center+, Maastricht, The Netherlands.; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center+, Maastricht, The Netherlands.
    Pokaż więcej
    Źródło:
    European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2018 Feb; Vol. 45 (2), pp. 179-186. Date of Electronic Publication: 2017 Sep 14.
    Typ publikacji:
    Journal Article
    MeSH Terms:
    Fluorodeoxyglucose F18*
    Positron Emission Tomography Computed Tomography*
    Breast Neoplasms/*diagnostic imaging
    Breast Neoplasms/*pathology
    Adult ; Aged ; Axilla ; Feasibility Studies ; Female ; Humans ; Lymph Nodes/diagnostic imaging ; Lymph Nodes/pathology ; Magnetic Resonance Imaging ; Middle Aged ; Neoplasm Staging
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknie Pełny tekstSzczegóły
    Tytuł:
    Hybrid F-FDG PET/MRI might improve locoregional staging of breast cancer patients prior to neoadjuvant chemotherapy.
    Autorzy:
    Goorts B; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands. .; Department of Surgery, Maastricht University Medical Center, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands. .; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, the Netherlands. .
    Vöö S; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, the Netherlands.
    van Nijnatten TJA; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.; Department of Surgery, Maastricht University Medical Center, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands.; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, the Netherlands.
    Kooreman LFS; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.; Department of Pathology, Maastricht University Medical Center, Maastricht, the Netherlands.
    de Boer M; Department of Medical Oncology, Maastricht University Medical Center, Maastricht, the Netherlands.
    Keymeulen KBMI; Department of Surgery, Maastricht University Medical Center, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands.
    Aarnoutse R; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.; Department of Surgery, Maastricht University Medical Center, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands.
    Wildberger JE; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, the Netherlands.
    Mottaghy FM; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, the Netherlands.; Department of Nuclear Medicine, RWTH Aachen University Hospital, Aachen, Germany.
    Lobbes MBI; Department of Radiology and Nuclear Medicine, Maastricht University Medical Center, Maastricht, the Netherlands.
    Smidt ML; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Center, Maastricht, the Netherlands.; Department of Surgery, Maastricht University Medical Center, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands.
    Pokaż więcej
    Źródło:
    European journal of nuclear medicine and molecular imaging [Eur J Nucl Med Mol Imaging] 2017 Oct; Vol. 44 (11), pp. 1796-1805. Date of Electronic Publication: 2017 Jun 10.
    Typ publikacji:
    Evaluation Study; Journal Article
    MeSH Terms:
    Breast Neoplasms/*diagnostic imaging
    Magnetic Resonance Imaging/*methods
    Multimodal Imaging/*methods
    Positron-Emission Tomography/*methods
    Adult ; Aged ; Breast Neoplasms/drug therapy ; Breast Neoplasms/pathology ; Chemotherapy, Adjuvant/methods ; Female ; Fluorodeoxyglucose F18 ; Humans ; Middle Aged ; Radiopharmaceuticals
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
    Tytuł:
    Clinically node negative breast cancer patients undergoing breast conserving therapy, sentinel lymph node procedure versus follow-up: a Dutch randomized controlled multicentre trial (BOOG 2013-08).
    Autorzy:
    van Roozendaal LM; Division of Surgical Oncology, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands.; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands.
    Vane MLG; Division of Surgical Oncology, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands. .; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands. .
    van Dalen T; Division of Surgical Oncology, Diakonessenhuis Hospital, Utrecht, the Netherlands.
    van der Hage JA; Division of Surgical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
    Strobbe LJA; Division of Surgical Oncology, Canisius-Wilhelmina Hospital, Nijmegen, the Netherlands.
    Boersma LJ; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands.; Department of Radiation Oncology, Maastricht University Medical Centre (MAASTRO clinic), Maastricht, the Netherlands.
    Linn SC; Division of Medical Oncology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
    Lobbes MBI; Department of Radiology and Nuclear Medicine, Maastricht University Medical Centre, Maastricht, the Netherlands.
    Poortmans PMP; Department of Radiation Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands.
    Tjan-Heijnen VCG; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands.; Division of Medical Oncology, Maastricht University Medical Centre, Maastricht, the Netherlands.
    Van de Vijver KKBT; Department of Pathology, Netherlands Cancer Institute - Antoni van Leeuwenhoek Hospital, Amsterdam, the Netherlands.
    de Vries J; Department of Medical and Clinical Psychology, Tilburg University, Tilburg, the Netherlands.
    Westenberg AH; Radiation Oncology, Radiotherapy group, Arnhem, the Netherlands.
    Kessels AGH; Department of Clinical Epidemiology and Medical Technology Assessment, Maastricht University Medical Centre, Maastricht, the Netherlands.
    de Wilt JHW; Division of Surgical Oncology, Radboud University Medical Centre, Nijmegen, the Netherlands.
    Smidt ML; Division of Surgical Oncology, Maastricht University Medical Centre, P.O. Box 5800, 6202 AZ, Maastricht, The Netherlands.; GROW - School for Oncology and Developmental Biology, Maastricht University Medical Centre, Maastricht, the Netherlands.
    Pokaż więcej
    Źródło:
    BMC cancer [BMC Cancer] 2017 Jul 01; Vol. 17 (1), pp. 459. Date of Electronic Publication: 2017 Jul 01.
    Typ publikacji:
    Clinical Trial; Journal Article; Multicenter Study; Randomized Controlled Trial
    MeSH Terms:
    Mastectomy, Segmental*/adverse effects
    Mastectomy, Segmental*/methods
    Breast Neoplasms/*pathology
    Breast Neoplasms/*surgery
    Combined Modality Therapy/adverse effects ; Combined Modality Therapy/methods ; Female ; Follow-Up Studies ; Humans ; Lymphatic Metastasis ; Neoplasm Recurrence, Local ; Neoplasm Staging ; Netherlands ; Quality of Life ; Retreatment ; Sentinel Lymph Node/pathology ; Sentinel Lymph Node Biopsy ; Treatment Outcome ; Watchful Waiting
    Czasopismo naukowe
    Pełny tekst  Link otwiera się w nowym oknieSzczegóły
      Wyświetlanie 1-12 z 12

      Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies